Carolin Dreyer

Laquinimod, a prototypic quinoline-3-carboxamide and aryl hydrocarbon receptor agonist, utilizes a CD155-mediated natural killer/dendritic cell interaction to suppress CNS autoimmunity

C. Wegner, W. Brück, C. Stadelmann, 2019, Journal of Neuroinflammation.

Laquinimod, a prototypic quinoline-3-carboxamide and aryl hydrocarbon receptor agonist, utilizes a CD155-mediated natural killer/dendritic cell interaction to suppress CNS autoimmunity

C. Wegner, W. Brück, C. Stadelmann, 2019, Journal of neuroinflammation.